Compare WMG & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WMG | ROIV |
|---|---|---|
| Founded | 1929 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.5B | 14.1B |
| IPO Year | 2020 | N/A |
| Metric | WMG | ROIV |
|---|---|---|
| Price | $29.39 | $21.91 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 8 |
| Target Price | ★ $36.07 | $24.31 |
| AVG Volume (30 Days) | 2.8M | ★ 7.9M |
| Earning Date | 02-05-2026 | 11-10-2025 |
| Dividend Yield | ★ 2.66% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.69 | N/A |
| Revenue | ★ $6,707,000,000.00 | $20,329,000.00 |
| Revenue This Year | $5.41 | N/A |
| Revenue Next Year | $5.86 | $376.94 |
| P/E Ratio | $41.16 | ★ N/A |
| Revenue Growth | ★ 4.37 | N/A |
| 52 Week Low | $25.56 | $8.73 |
| 52 Week High | $36.64 | $23.47 |
| Indicator | WMG | ROIV |
|---|---|---|
| Relative Strength Index (RSI) | 54.05 | 58.99 |
| Support Level | $27.60 | $20.14 |
| Resistance Level | $28.44 | $23.47 |
| Average True Range (ATR) | 0.77 | 0.86 |
| MACD | 0.23 | 0.08 |
| Stochastic Oscillator | 62.46 | 54.42 |
Warner Music is the third-largest of the three major record companies. Recorded music accounts for most of the firm's revenue, with the segment housing notable record labels including Atlantic Records, Warner Records, Elektra Records. Some of the most successful current artists signed to record deals with Warner include Ed Sheeran, Bruno Mars, Cardi B, and Dua Lipa. Warner's remaining revenue comes from its publishing business, where Warner Chappell represents more than 180,000 songwriters and composers, some of whom are also Warner recording artists but many of whom are not recording artists or are attached to other labels. Warner Chappell controls more than 1 million musical compositions. Access Industries controls 98% of Warner's voting rights, while holding a 72% economic interest.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.